R&D Systems™ Recombinant Human IL-17E Protein

Catalog No.	Formulation
1258IL025	Lyophilized from a 0.2 μm filtered solution in acetonitrile and TFA with BSA as a carrier protein.
1258IL025CF	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.

Catalog No. 1258IL025 Supplier R&D Systems™ Supplier No. 1258IL025

Description

A New and Improved rh IL-17E is Now Available! The new protein is mammalian cell expressed!

Measured by its ability to induce CXCL1/GRO alpha secretion in HT-29 human colon adenocarcinoma cells. The ED50 for this effect is 0.25-1.5 ng/mL.

Specifications

• Accession Number: Q9H293
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in acetonitrile and TFA with BSA as a carrier protein.
• Gene ID (Entrez): 64806
• Molecular Weight (g/mol): M.W. (theoretical): 17 kDa (monomer)
• Name: IL-17E/IL-25
• Quantity: 25 μg
• Source: E. coli-derived human IL-17 E/IL-25 protein Tyr33-Gly177, with an N-terminal Met
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: IL25
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in sterile 4 mM HCl containing (at least 0.1% human or bovine serum albumin.)
• Purity or Quality Grade: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Protein: IL-17 E/IL-25